| 臺大學術典藏 |
2021-03-09T01:47:35Z |
Peginterferon alfa-2a with or without low-dose ribavirin for treatment-naive patients with hepatitis C virus genotype 2 receiving haemodialysis: A randomised trial
|
Liu C.-H.; Liu C.-J.; Huang C.-F.; Lin J.-W.; Dai C.-Y.; Liang C.-C.; Huang J.-F.; Hung P.-H.; Tsai H.-B.; Tsai M.-K.; Lee C.-Y.; Chen S.-I.; Yang S.-S.; TUNG-HUNG SU; Yang H.-C.; Chen P.-J.; Chen D.-S.; Chuang W.-L.; Yu M.-L.; Kao J.-H. |
| 臺大學術典藏 |
2021-05-24T07:20:34Z |
Peginterferon alfa-2a with or without low-dose ribavirin for treatment-naive patients with hepatitis C virus genotype 2 receiving haemodialysis: A randomised trial
|
CHEN-HUA LIU; Liu C.-J.; Huang C.-F.; Lin J.-W.; Dai C.-Y.; Liang C.-C.; Huang J.-F.; Hung P.-H.; Tsai H.-B.; Tsai M.-K.; Lee C.-Y.; Chen S.-I.; Yang S.-S.; Su T.-H.; Yang H.-C.; Chen P.-J.; Chen D.-S.; Chuang W.-L.; Yu M.-L.; Kao J.-H. |
| 臺大學術典藏 |
2021-07-03T03:33:58Z |
Peginterferon alfa-2a with or without low-dose ribavirin for treatment-naive patients with hepatitis C virus genotype 2 receiving haemodialysis: A randomised trial
|
Liu C.-H.; Liu C.-J.; Huang C.-F.; Lin J.-W.; Dai C.-Y.; Liang C.-C.; Huang J.-F.; Hung P.-H.; Tsai H.-B.; Tsai M.-K.; Lee C.-Y.; Chen S.-I.; Yang S.-S.; Su T.-H.; Yang H.-C.; PEI-JER CHEN; Chen D.-S.; Chuang W.-L.; Yu M.-L.; Kao J.-H. |
| 臺大學術典藏 |
2021-07-12T02:44:40Z |
Peginterferon alfa-2a with or without low-dose ribavirin for treatment-naive patients with hepatitis C virus genotype 2 receiving haemodialysis: A randomised trial
|
Liu C.-H; | Liu C.-J; | Huang C.-F; | Lin J.-W; | Dai C.-Y; | Liang C.-C; | Huang J.-F; | Hung P.-H; | Tsai H.-B; | Tsai M.-K; | Lee C.-Y; | Chen S.-I; | Yang S.-S; | Su T.-H; | HUNG-CHIH YANG; | Chen P.-J; | Chen D.-S; | Chuang W.-L; | Yu M.-L; | Kao J.-H. |
| 臺大學術典藏 |
2022-01-24T09:31:33Z |
Peginterferon alfa-2a with or without low-dose ribavirin for treatment-naive patients with hepatitis C virus genotype 2 receiving haemodialysis: A randomised trial
|
Liu C.-H.; CHUN-JEN LIU; Huang C.-F.; Lin J.-W.; Dai C.-Y.; Liang C.-C.; Huang J.-F.; Hung P.-H.; Tsai H.-B.; Tsai M.-K.; Lee C.-Y.; Chen S.-I.; Yang S.-S.; Su T.-H.; Yang H.-C.; Chen P.-J.; Chen D.-S.; Chuang W.-L.; Yu M.-L.; Kao J.-H. |
| 臺大學術典藏 |
2022-01-07T06:05:52Z |
Peginterferon alfa-2a with or without low-dose ribavirin for treatment-naive patients with hepatitis C virus genotype 2 receiving haemodialysis: A randomised trial
|
Liu C.-H.; Liu C.-J.; Huang C.-F.; Lin J.-W.; Dai C.-Y.; Liang C.-C.; Huang J.-F.; Hung P.-H.; Tsai H.-B.; Tsai M.-K.; CHIH-YUAN LEE; Chen S.-I.; Yang S.-S.; Su T.-H.; Yang H.-C.; Chen P.-J.; Chen D.-S.; Chuang W.-L.; Yu M.-L.; Kao J.-H. |
| 國立臺灣大學 |
2009 |
Peginterferon Alfa-2b or Alfa-2a with Ribavirin for Hepatitis C
|
許景盛; 高嘉宏; HSU, CHING-SHENG; KAO, JIA-HORNG |
| 臺大學術典藏 |
2018-09-10T07:39:50Z |
Peginterferon alfa-2b or alfa-2a with ribavirin for hepatitis C
|
Hsu, C.-S.;Kao, J.-H.; JIA-HORNG KAO |
| 臺大學術典藏 |
2021-09-04T06:12:23Z |
Peginterferon alfa-2b or alfa-2a with ribavirin for hepatitis C
|
Hsu C.-S.; JIA-HORNG KAO |
| 國立成功大學 |
2016-05 |
Peginterferon lambda for the treatment of HBeAg-positive chronic hepatitis B: A randomized phase 2b study (LIRA-B)
|
Chan, Henry L. Y.;Ahn, Sang Hoon;Chang, Ting-Tsung;Peng, Cheng-Yuan;Wong, David;Coffin, Carla S.;Lim, Seng Gee;Chen, Pei-Jer;Janssen, Harry L. A.;Marcellin, Patrick;Serfaty, Lawrence;Zeuzem, Stefan;Cohen, David;Critelli, Linda;Xu, Dong;Wind-Rotolo, Megan;Cooney, Elizabeth |
| 臺大學術典藏 |
2021-07-03T03:33:52Z |
Peginterferon lambda for the treatment of HBeAg-positive chronic hepatitis B: A randomized phase 2b study (LIRA-B)
|
Chan H.L.Y.;Ahn S.H.;Chang T.-T.;Peng C.-Y.;Wong D.;Coffin C.S.;Lim S.G.;Pei-Jer Chen;Janssen H.L.A.;Marcellin P.;Serfaty L.;Zeuzem S.;Cohen D.;Critelli L.;Xu D.;Wind-Rotolo M.;Cooney E.;Lira-B Study Team; Chan H.L.Y.; Ahn S.H.; Chang T.-T.; Peng C.-Y.; Wong D.; Coffin C.S.; Lim S.G.; PEI-JER CHEN; Janssen H.L.A.; Marcellin P.; Serfaty L.; Zeuzem S.; Cohen D.; Critelli L.; Xu D.; Wind-Rotolo M.; Cooney E.; LIRA-B Study Team |
| 國立成功大學 |
2012-12 |
Peginterferon Lambda, a New Potential Therapeutic Option for the Treatment of Chronic Hepatitis B: A Phase 2B Comparison with Peginterferon Alfa in Patients with HBeAg-Positive Disease
|
Chan, Henry Lik-Yuen; Ahn, Sang Hoon; Chang, Ting-Tsung; Peng, Cheng-Yuan; Wong, David K.; Coffin, Carla S.; Lim, Seng Gee; Chen, Pei-Jer; Janssen, Harry L.; Marcellin, Patrick; Serfaty, Lawrence; Zeuzem, Stefan; Hu, Wenhua; Critelli, Linda; Lopez-Talavera, Juan Carlos; Cooney, Elizabeth L. |
| 臺大學術典藏 |
2018-09-10T15:35:07Z |
Peginterferon Lambda-1a/ribavirin with daclatasvir or peginterferon alfa-2a/ribavirin with telaprevir for chronic hepatitis c genotype 1b
|
Flisiak, R.;Kawazoe, S.;Znoyko, O.;Assy, N.;Gadano, A.;Kao, J.-H.;Lee, K.-S.;Zwirtes, R.;Portsmouth, S.;Dong, Y.;Xu, D.;Kumada, H.;Srinivasan, S.; JIA-HORNG KAO |
| 臺大學術典藏 |
2021-09-04T06:11:09Z |
Peginterferon Lambda-1a/ribavirin with daclatasvir or peginterferon alfa-2a/ribavirin with telaprevir for chronic hepatitis c genotype 1b
|
Flisiak R.; Kawazoe S.; Znoyko O.; Assy N.; Gadano A.; JIA-HORNG KAO; Lee K.-S.; Zwirtes R.; Portsmouth S.; Dong Y.; Xu D.; Kumada H.; Srinivasan S. |
| 國立臺灣大學 |
2015 |
Peginterferon plus Ribavirin for HIV-infected Patients with Treatment-Naive Acute or Chronic HCV Infection in Taiwan: A Prospective Cohort Study
|
Liu, Chen-Hua; Sheng, Wang-Hui; Sun, Hsin-Yun; Hsieh, Szu-Min; Lo, Yi-Chun; Liu, Chun-Jen; Su, Tung-Hung; Yang, Hung-Chih; Liu, Wen-Chun; Chen, Pei-Jer; Chen, Ding-Shinn; Hung, Chien-Ching; Kao, Jia-Horng; 陳定信; 劉振驊; 高嘉宏; 楊宏志; 蘇東弘; 孫幸筠; 劉俊人; 謝思民; 陳培哲; 盛望徽; 洪健清 |
| 中國醫藥大學 |
2015-11 |
Peginterferon plus Ribavirin for HIV-infected Patients with Treatment-Naive Acute or Chronic HCV Infection in Taiwan: A Prospective Cohort Study
|
(Liu, Chen-Hua);(Sheng, Wang-Hui);(Sun, Hsin-Yun);(Hsieh, Szu-Min);(.....);洪健清(Chien-Ching Hung)*;(Kao, Jia-Horng) |
| 臺大學術典藏 |
2021-09-04T06:11:21Z |
Peginterferon plus Ribavirin for HIV-infected Patients with Treatment-Naive Acute or Chronic HCV Infection in Taiwan: A Prospective Cohort Study
|
Liu C.-H.; Sheng W.-H.; Sun H.-Y.; Hsieh S.-M.; Lo Y.-C.; Liu C.-J.; Su T.-H.; Yang H.-C.; Liu W.-C.; Chen P.-J.; Chen D.-S.; Hung C.-C.; JIA-HORNG KAO |
| 臺大學術典藏 |
2015 |
Peginterferon plus Ribavirin for HIV-infected Patients with Treatment-Naive Acute or Chronic HCV Infection in Taiwan: A Prospective Cohort Study
|
Liu C.-H.; Sheng W.-H.; Sun H.-Y.; Hsieh S.-M.; Lo Y.-C.; Liu C.-J.; Su T.-H.; Yang H.-C.; Liu W.-C.; Chen P.-J.; Chen D.-S.; CHIEN-CHING HUNG; Kao J.-H. |
| 臺大學術典藏 |
2015 |
Peginterferon plus Ribavirin for HIV-infected Patients with Treatment-Naive Acute or Chronic HCV Infection in Taiwan: A Prospective Cohort Study
|
Sheng W.-H.; Liu C.-H.; HSIN-YUN SUN; Hsieh S.-M.; Lo Y.-C.; Liu C.-J.; Su T.-H.; Yang H.-C.; Liu W.-C.; Chen P.-J.; Chen D.-S.; Hung C.-C.; Kao J.-H. |
| 臺大學術典藏 |
2021-03-09T01:47:34Z |
Peginterferon plus Ribavirin for HIV-infected Patients with Treatment-Naive Acute or Chronic HCV Infection in Taiwan: A Prospective Cohort Study
|
Liu C.-H.; Sheng W.-H.; Sun H.-Y.; Hsieh S.-M.; Lo Y.-C.; Liu C.-J.; TUNG-HUNG SU; Yang H.-C.; Liu W.-C.; Chen P.-J.; Chen D.-S.; Hung C.-C.; Kao J.-H. |
| 臺大學術典藏 |
2021-07-03T03:33:56Z |
Peginterferon plus Ribavirin for HIV-infected Patients with Treatment-Naive Acute or Chronic HCV Infection in Taiwan: A Prospective Cohort Study
|
Liu C.-H.; Sheng W.-H.; Sun H.-Y.; Hsieh S.-M.; Lo Y.-C.; Liu C.-J.; Su T.-H.; Yang H.-C.; Liu W.-C.; PEI-JER CHEN; Chen D.-S.; Hung C.-C.; Kao J.-H. |
| 臺大學術典藏 |
2021-07-12T02:44:39Z |
Peginterferon plus Ribavirin for HIV-infected Patients with Treatment-Naive Acute or Chronic HCV Infection in Taiwan: A Prospective Cohort Study
|
Liu C.-H; | Sheng W.-H; | Sun H.-Y; | Hsieh S.-M; | Lo Y.-C; | Liu C.-J; | Su T.-H; | HUNG-CHIH YANG; | Liu W.-C; | Chen P.-J; | Chen D.-S; | Hung C.-C; | Kao J.-H. |
| 臺大學術典藏 |
2020-12-29T06:37:47Z |
Peginterferon plus Ribavirin for HIV-infected Patients with Treatment-Naive Acute or Chronic HCV Infection in Taiwan: A Prospective Cohort Study
|
Su T.-H.; Liu C.-J.; Lo Y.-C.; SZU-MIN HSIEH; Sheng W.-H.; Sun H.-Y.; Liu C.-H.; Yang H.-C.; Liu W.-C.; Chen P.-J.; Chen D.-S.; Hung C.-C.; Kao J.-H. |
| 臺大學術典藏 |
2022-01-24T09:31:31Z |
Peginterferon plus Ribavirin for HIV-infected Patients with Treatment-Naive Acute or Chronic HCV Infection in Taiwan: A Prospective Cohort Study
|
Liu C.-H.; Sheng W.-H.; Sun H.-Y.; Hsieh S.-M.; Lo Y.-C.; CHUN-JEN LIU; Su T.-H.; Yang H.-C.; Liu W.-C.; Chen P.-J.; Chen D.-S.; Hung C.-C.; Kao J.-H. |
| 臺大學術典藏 |
2021-02-26T01:59:37Z |
Peginterferon plus Ribavirin for HIV-infected Patients with Treatment-Naive Acute or Chronic HCV Infection in Taiwan: A Prospective Cohort Study
|
Liu C.-H.;Wang-Huei Sheng;Sun H.-Y.;Hsieh S.-M.;Lo Y.-C.;Liu C.-J.;Su T.-H.;Yang H.-C.;Liu W.-C.;Chen P.-J.;Chen D.-S.;Hung C.-C.;Kao J.-H.; Liu C.-H.; WANG-HUEI SHENG; Sun H.-Y.; Hsieh S.-M.; Lo Y.-C.; Liu C.-J.; Su T.-H.; Yang H.-C.; Liu W.-C.; Chen P.-J.; Chen D.-S.; Hung C.-C.; Kao J.-H. |
| 臺大學術典藏 |
2021-05-24T07:20:33Z |
Peginterferon plus Ribavirin for HIV-infected Patients with Treatment-Naive Acute or Chronic HCV Infection in Taiwan: A Prospective Cohort Study
|
CHEN-HUA LIU; Sheng W.-H.; Sun H.-Y.; Hsieh S.-M.; Lo Y.-C.; Liu C.-J.; Su T.-H.; Yang H.-C.; Liu W.-C.; Chen P.-J.; Chen D.-S.; Hung C.-C.; Kao J.-H. |
| 臺大學術典藏 |
2018-09-10T15:24:57Z |
Peginterferon plus Ribavirin for HIV-infected Patients with Treatment-Naïve Acute or Chronic HCV Infection in Taiwan: A Prospective Cohort Study.
|
Chen-Hua Liu, Wang-Hui Sheng, Hsin-Yun Sun, Szu-Min Hsieh, Yi-Chun Lo, Chun-Jen Liu, Tung-Hung Su, Hung-Chih Yang, Wen-Chun Liu, Pei-Jer Chen, Ding-Shinn Chen, Chien-Ching Hung, Jia-Horng Kao; Liu, Chen-Hua;Sheng, Wang-Hui;Sun, Hsin-Yun;Hsieh, Szu-Min;Lo, Yi-Chun;Liu, Chun-Jen;Su, Tung-Hung;Yang, Hung-Chih;Liu, Wen-Chun;Chen, Pei-Jer;Chen, Ding-Shinn;Hung, Chien-Ching;Kao, Jia-Horng; 陳定信;劉振驊;高嘉宏;楊宏志;蘇東弘;孫幸筠;劉俊人;謝思民;陳培哲;盛望徽;洪健清; Chang, Tien-Jyun; Liu, Chen-Hua; HUNG-CHIH YANG; Sheng, Wang-Hui; CHUN-JEN LIU; Tseng, Hsing-Chi; Sun, Hsin-Yun; Liu, Meng-Wei; SZU-MIN HSIEH; PEI-JER CHEN; Chang, Yi-Cheng; Hsieh, Szu-Min; Hsieh, Meng-Lun; Lo, Yi-Chun; CHEN-HUA LIU; Liu, Chun-Jen; Chuang, Lee-Ming; DING-SHINN CHEN; TUNG-HUNG SU; Su, Tung-Hung; Yang, Hung-Chih; HSIN-YUN SUN; Liu, Wen-Chun; JIA-HORNG KAO; CHIEN-CHING HUNG; Chen, Pei-Jer; Chen, Ding-Shinn; Hung, Chien-Ching; Kao, Jia-Horng; ?????; ?i?H??; ?i??g; ?????? |
| 臺大學術典藏 |
2021-07-03T03:33:59Z |
Peginterferon plus weight-based ribavirin for treatment-na?ve hepatitis C virus genotype 2 patients not achieving rapid virologic response: A randomized trial
|
Liu C.-H.; Huang C.-F.; Liu C.-J.; Dai C.-Y.; Huang J.-F.; Lin J.-W.; Liang C.-C.; Yang S.-S.; Lin C.-L.; Su T.-H.; Yang H.-C.; PEI-JER CHEN; Chen D.-S.; Chuang W.-L.; Kao J.-H.; Yu M.-L. |
| 臺大學術典藏 |
2021-07-12T02:44:41Z |
Peginterferon plus weight-based ribavirin for treatment-na?ve hepatitis C virus genotype 2 patients not achieving rapid virologic response: A randomized trial
|
Liu C.-H; | Huang C.-F; | Liu C.-J; | Dai C.-Y; | Huang J.-F; | Lin J.-W; | Liang C.-C; | Yang S.-S; | Lin C.-L; | Su T.-H; | HUNG-CHIH YANG; | Chen P.-J; | Chen D.-S; | Chuang W.-L; | Kao J.-H; | Yu M.-L. |
| 臺大學術典藏 |
2021-09-04T06:11:25Z |
Peginterferon plus weight-based ribavirin for treatment-na?ve hepatitis C virus genotype 2 patients not achieving rapid virologic response: A randomized trial
|
Liu C.-H.; Huang C.-F.; Liu C.-J.; Dai C.-Y.; Huang J.-F.; Lin J.-W.; Liang C.-C.; Yang S.-S.; Lin C.-L.; Su T.-H.; Yang H.-C.; Chen P.-J.; Chen D.-S.; Chuang W.-L.; JIA-HORNG KAO; Yu M.-L. |
| 臺大學術典藏 |
2022-01-24T09:31:34Z |
Peginterferon plus weight-based ribavirin for treatment-na?ve hepatitis C virus genotype 2 patients not achieving rapid virologic response: A randomized trial
|
Liu C.-H.; Huang C.-F.; CHUN-JEN LIU; Dai C.-Y.; Huang J.-F.; Lin J.-W.; Liang C.-C.; Yang S.-S.; Lin C.-L.; Su T.-H.; Yang H.-C.; Chen P.-J.; Chen D.-S.; Chuang W.-L.; Kao J.-H.; Yu M.-L. |
| 國立臺灣大學 |
2015 |
Peginterferon plus weight-based ribavirin for treatment-naive hepatitis C virus genotype 2 patients not achieving rapid virologic response: a randomized trial
|
Liu, Chen-Hua; Huang, Chung-Feng; Liu, Chun-Jen; Dai, Chia-Yen; Huang, Jee-Fu; Lin, Jou-Wei; Liang, Cheng-Chao; Yang, Sheng-Shun; Lin, Chih-Lin; Su, Tung-Hung; Yang, Hung-Chih; Chen, Pei-Jer; Chen, Ding-Shinn; Chuang, Wan-Long; Kao, Jia-Horng; Yu, Ming-Lung; 陳定信; 劉振驊; 高嘉宏; 楊宏志; 蘇東弘; 劉俊人; 陳培哲; 林昭維 |
| 臺大學術典藏 |
2018-09-10T15:18:57Z |
Peginterferon plus weight-based ribavirin for treatment-naïve hepatitis C virus genotype 2 patients not achieving rapid virologic response: A randomized trial
|
Liu, Chen-Hua;Huang, Chung-Feng;Liu, Chun-Jen;Dai, Chia-Yen;Huang, Jee-Fu;Lin, Jou-Wei;Liang, Cheng-Chao;Yang, Sheng-Shun;Lin, Chih-Lin;Su, Tung-Hung;Yang, Hung-Chih;Chen, Pei-Jer;Chen, Ding-Shinn;Chuang, Wan-Long;Kao, Jia-Horng;Yu, Ming-Lung; Liu, Chen-Hua;Huang, Chung-Feng;Liu, Chun-Jen;Dai, Chia-Yen;Huang, Jee-Fu;Lin, Jou-Wei;Liang, Cheng-Chao;Yang, Sheng-Shun;Lin, Chih-Lin;Su, Tung-Hung;Yang, Hung-Chih;Chen, Pei-Jer;Chen, Ding-Shinn;Chuang, Wan-Long;Kao, Jia-Horng;Yu, Ming-Lung; Liu, C.-H. and Huang, C.-F. and Liu, C.-J. and Dai, C.-Y. and Huang, J.-F. and Lin, J.-W. and Liang, C.-C. and Yang, S.-S. and Lin, C.-L. and Su, T.-H. and Yang, H.-C. and Chen, P.-J. and Chen, D.-S. and Chuang, W.-L. and Kao, J.-H. and Yu, M.-L.; 陳定信;劉振驊;高嘉宏;楊宏志;蘇東弘;劉俊人;陳培哲;林昭維; Wu, Cho-Kai; Liu, Chen-Hua; HUNG-CHIH YANG; CHUN-JEN LIU; Su, Mao-Yuan; Huang, Chung-Feng; PEI-JER CHEN; Lee, Jen-Kuang; Liu, Chun-Jen; Dai, Chia-Yen; Chiang, Fu-Tien; CHEN-HUA LIU; Hwang, Juey-Jen; Huang, Jee-Fu; DING-SHINN CHEN; Lin, Jiunn-Lee; TUNG-HUNG SU; Lin, Jou-Wei; JIA-HORNG KAO; Chen, Jin-Jer; Liang, Cheng-Chao; Yang, Sheng-Shun; Liu, Fu-Tong; Lin, Chih-Lin; Tsai, Chia-Ti; Su, Tung-Hung; Yang, Hung-Chih; Chen, Pei-Jer; Chen, Ding-Shinn; Chuang, Wan-Long; Kao, Jia-Horng; Yu, Ming-Lung; ??????; ?L?T??; ?????; ??Z??; ?d????; ???礯; ?????? |
| 臺大學術典藏 |
2021-03-09T01:47:36Z |
Peginterferon plus weight-based ribavirin for treatment-naïve hepatitis C virus genotype 2 patients not achieving rapid virologic response: A randomized trial
|
Liu C.-H.; Huang C.-F.; Liu C.-J.; Dai C.-Y.; Huang J.-F.; Lin J.-W.; Liang C.-C.; Yang S.-S.; Lin C.-L.; TUNG-HUNG SU; Yang H.-C.; Chen P.-J.; Chen D.-S.; Chuang W.-L.; Kao J.-H.; Yu M.-L. |
| 臺大學術典藏 |
2021-05-24T07:20:34Z |
Peginterferon plus weight-based ribavirin for treatment-naïve hepatitis C virus genotype 2 patients not achieving rapid virologic response: A randomized trial
|
CHEN-HUA LIU; Huang C.-F.; Liu C.-J.; Dai C.-Y.; Huang J.-F.; Lin J.-W.; Liang C.-C.; Yang S.-S.; Lin C.-L.; Su T.-H.; Yang H.-C.; Chen P.-J.; Chen D.-S.; Chuang W.-L.; Kao J.-H.; Yu M.-L. |
| 臺大學術典藏 |
2018-09-10T14:59:14Z |
Peginterferon α in the treatment of chronic hepatitis B
|
Tseng, T.-C.; Kao, J.-H.; Chen, D.-S.; DING-SHINN CHEN; JIA-HORNG KAO |
| 臺大學術典藏 |
2021-09-04T06:11:41Z |
Peginterferon α in the treatment of chronic hepatitis B
|
Tseng T.-C.; JIA-HORNG KAO; Chen D.-S. |
| 南台科技大學 |
2005-11 |
Pegradation of gaseous propanol under visible light irradiation using thermal nitrogen-plasma treated titanium dioxide nanotube
|
李友竹; C. M. Huang ; Y. C. M. Li ; J. C. Chung; G. T. Pan |
| 國家衛生研究院 |
2014-12 |
Pegylated arginine deiminase (ADI-PEG20) in relapsed/refractory and/or elder Acute Myeloid Leukemia: The preliminary result of phase II trial
|
Tsai, HJ;Wang, MC;Lin, SF;Chen, YP;Hsiao, HH;Kuo, CY;Chen, LT;Chen, TY |
| 國立成功大學 |
2014-12-06 |
Pegylated Arginine Deiminase (ADI-PEG20) in Relapsed/Refractory and/or Elder Acute Myeloid Leukemia: The Preliminary Result of Phase II Trial
|
TTsai, Hui-Jen; Wang, Ming-Chung; Lin, Sheng-Fung; Chen, Ya-Ping; Hsiao, Hui-Hwa; Kuo, Ching-Yuan; Chen, Li-Tzong; Chen, Tsai-Yun |
| 國立成功大學 |
2015-06 |
Pegylated disintegrin exhibits more potent antithrombotic activity in vivo
|
Hsu, C-C; Chuang, W-J; Huang, T-F |
| 國立臺灣大學 |
2015 |
Pegylated disintegrin exhibits more potent antithrombotic activity in vivo
|
Hsu, C-C; Chuang, W-J; Huang, T-F; 黃德富 |
| 國立臺灣海洋大學 |
2014-03 |
Pegylated Gold Nanoparticles Induce Apoptosis in Human Chronic Myeloid Leukemia Cells
|
Y. S. Chu; E. Nazaretski; X. Huang; Y. Hwu; H. Yan; K. Lauer; R. Conley; N. Bouet; J. Zhou; W. Xu; D. Eom; D. Legnini; R. Harder; C.-H. Lin; Y.-S. Chen |
| 臺大學術典藏 |
2021-05-07T06:48:02Z |
Pegylated gold nanoparticles induce apoptosis in human chronic myeloid leukemia cells
|
Huang Y.-C.; Yang Y.-C.; KAI-CHIEN YANG; Shieh H.-R.; Wang T.-Y.; Hwu Y.; Chen Y.-J. |
| 國立臺灣大學 |
2011 |
Pegylated Guanidinylated Polyallylamine as Gene-Delivery Carrier
|
鍾易辰; 魏明鋒; 張富雄; 楊台鴻; CHUNG, YI-CHEN; WEI, MING-FENG; CHANG, FU-HSIUNG; YOUNG, TAI-HORNG |
| 臺大學術典藏 |
2020-01-21T06:05:56Z |
PEGylated guanidinylated polyallylamine as gene-delivery carrier
|
Chung Y.-C. ;Wei M.-F. ;Fu-Hsiung Chang ;Young T.-H.; Chung Y.-C.; Wei M.-F.; FU-HSIUNG CHANG; Young T.-H. |
| 中國醫藥大學 |
2011-09-10 |
PEGylated Herbal -loaded Nanoparticles for Cancer Therapy: Synthesis, Characterization, and Functionality
|
周志謂(Chih-Wei Chou) |
| 國家衛生研究院 |
2016-12-20 |
Pegylated IFN-alpha suppresses hepatitis C virus by promoting the DAPK-mTOR pathway
|
Liu, WL;Yang, HC;Hsu, CS;Wang, CC;Wang, TS;Kao, JH;Chen, DS |
| 國立臺灣大學 |
2016 |
Pegylated IFN-alpha suppresses hepatitis C virus by promoting the DAPK-mTOR pathway
|
Liu, Wei-Liang; Yang, Hung-Chih; Hsu, Ching-Sheng; Wang, Chih-Chiang; Wang, Tzu-San; Kao, Jia-Horng; Chen, Ding-Shinn; 陳定信; 高嘉宏; 楊宏志 |
| 臺大學術典藏 |
2018-09-10T15:34:51Z |
Pegylated IFN-α suppresses hepatitis C virus by promoting the DAPK-mTOR pathway
|
Liu, Wei-Liang;Yang, Hung-Chih;Hsu, Ching-Sheng;Wang, Chih-Chiang;Wang, Tzu-San;Kao, Jia-Horng;Chen, Ding-Shinn; Liu, Wei-Liang; HUNG-CHIH YANG; DING-SHINN CHEN; Yang, Hung-Chih; Yang, Hung-Chih; JIA-HORNG KAO; Hsu, Ching-Sheng; Wang, Chih-Chiang; Wang, Chih-Chiang; Wang, Tzu-San; Wang, Tzu-San; Kao, Jia-Horng; Kao, Jia-Horng; Chen, Ding-Shinn |
